Van den Berghe G - Search Results

1

Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness?

Vanhorebeek I, Langouche L, Van den Berghe G. Vanhorebeek I, et al. Among authors: van den berghe g. Curr Opin Crit Care. 2005 Aug;11(4):304-11. doi: 10.1097/01.ccx.0000170506.61281.94. Curr Opin Crit Care. 2005. PMID: 16015107 Review.

2

Dehydroepiandrosterone sulphate in critical illness: effect of dopamine.

Van den Berghe G, de Zegher F, Wouters P, Schetz M, Verwaest C, Ferdinande P, Lauwers P. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1995 Oct;43(4):457-63. doi: 10.1111/j.1365-2265.1995.tb02618.x. Clin Endocrinol (Oxf). 1995. PMID: 7586621 Clinical Trial.

3

Dopamine suppresses pituitary function in infants and children.

Van den Berghe G, de Zegher F, Lauwers P. Van den Berghe G, et al. Crit Care Med. 1994 Nov;22(11):1747-53. Crit Care Med. 1994. PMID: 7956277 Clinical Trial.

4

Growth hormone secretion in critical illness: effect of dopamine.

Van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD. Van den Berghe G, et al. J Clin Endocrinol Metab. 1994 Oct;79(4):1141-6. doi: 10.1210/jcem.79.4.7962286. J Clin Endocrinol Metab. 1994. PMID: 7962286 Clinical Trial.

5

Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.

Van den Berghe G, de Zegher F, Vlasselaers D, Schetz M, Verwaest C, Ferdinande P, Lauwers P. Van den Berghe G, et al. Crit Care Med. 1996 Apr;24(4):590-5. doi: 10.1097/00003246-199604000-00007. Crit Care Med. 1996. PMID: 8612408 Clinical Trial.

6

Anterior pituitary function during critical illness and dopamine treatment.

Van den Berghe G, de Zegher F. Van den Berghe G, et al. Crit Care Med. 1996 Sep;24(9):1580-90. doi: 10.1097/00003246-199609000-00024. Crit Care Med. 1996. PMID: 8797634 Review.

7

Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.

Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1996 Sep;45(3):341-51. doi: 10.1046/j.1365-2265.1996.00805.x. Clin Endocrinol (Oxf). 1996. PMID: 8949573 Clinical Trial.

8

Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit.

Verwaest C, Verhaegen J, Ferdinande P, Schetz M, Van den Berghe G, Verbist L, Lauwers P. Verwaest C, et al. Among authors: van den berghe g. Crit Care Med. 1997 Jan;25(1):63-71. doi: 10.1097/00003246-199701000-00014. Crit Care Med. 1997. PMID: 8989178 Clinical Trial.

9

The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.

Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY. Van den Berghe G, et al. J Clin Endocrinol Metab. 1997 Feb;82(2):590-9. doi: 10.1210/jcem.82.2.3736. J Clin Endocrinol Metab. 1997. PMID: 9024260 Clinical Trial.

10

Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.

Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Gouwy S, Stockman W, Weekers F, Schetz M, Lauwers P, Bouillon R, Bowers CY. Van den Berghe G, et al. Clin Endocrinol (Oxf). 1997 Nov;47(5):599-612. doi: 10.1046/j.1365-2265.1997.3371118.x. Clin Endocrinol (Oxf). 1997. PMID: 9425400 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

625 results

Search Page

Filters